Mignani, Renzo https://orcid.org/0000-0001-8507-8939
Biagini, Elena
Cianci, Vittoria
Pieruzzi, Federico
Pisani, Antonio
Tuttolomondo, Antonino
Pieroni, Maurizio
Funding for this research was provided by:
Sanofi Italia
Article History
Received: 11 July 2024
Accepted: 17 October 2024
First Online: 5 December 2024
Declarations
:
: Renzo Mignani has received speaker and advisory board honoraria and travel support from Amicus Therapeutics, Chiesi, Takeda, and Sanofi. Maurizio Pieroni has received speaker and advisory board honoraria and travel support from Amicus Therapeutics, Chiesi, Takeda, and Sanofi. Elena Biagini has received speaker and advisory board honoraria and travel support from Amicus Therapeutics, Chiesi, Takeda, Genzyme, and BMS. Vittoria Cianci, Federico Pieruzzi, Antonio Pisani, and Antonino Tuttolomondo have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.